Skip to main content

Advertisement

Log in

Bilateral subthalamic nucleus stimulation in advanced Parkinson’s disease: Five year follow-up

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Objective

To assess the long-term efficacy and safety of bilateral subthalamic nucleus (STN) stimulation in patients with advanced Parkinson’s disease (PD).

Methods

42 consecutive patients with idiopathic PD treated with bilateral STN stimulation were enrolled. Parkinsonian status, medication intake and neuropsychological evaluation were assessed preoperatively and at 1 and 5 years postoperatively in on and off medication/on and off stimulation conditions.

Results

23 patients could be followed-up 5 years after surgery. In the remaining cases, 5 died, 1 could not be assessed because of device removal for infection, 1 decided not to be stimulated, and 11 were lost of follow-up (one because of a liver carcinoma and the others because they refused the formal four conditions of assessment). STN stimulation reduced the UPDRS motor score by 55 % compared to baseline in the offmedication conditions. Tremor, rigidity, bradykinesia, postural stability, and gait improved by 74 %, 66 %, 59 %, 17 % and 37 %, respectively. UPDRS part II scores were reduced by 38 %. The dopaminergic treatment daily dose was reduced by 54.4 % after surgery. Axial dopa-unresponsive signs worsened in some patients. Among the 42 initial patients we observed the following: 2 brain hemorrhages, 3 infections of the device, 2 phlebitis and 1 pulmonary embolism. In addition, 2 patients needed a repositioning of the electrode. Among the 23 patients followed at 5 years, long lasting side effects consisted in dysarthria (56 %), depression (39 %), eyelid opening apraxia (30.4 %) and apathy (4.3 %).

Conclusions

Our data confirm that bilateral STN stimulation is beneficial in the long-term for PD patients but does not prevent disease progression and the occurence of axial levodopa unresponsive signs in some patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP (2005) Pallidal vs Subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol 62:554–560

    Article  PubMed  Google Scholar 

  2. Appleby BS, Duggan PS, Regenberg A, Rabins PV (2007) Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: A metaanalysis of ten years’ experience. Mov Disord 22(12):1722–1728

    Article  PubMed  Google Scholar 

  3. Ardouin C, Pillon B, Peiffer E, Bejjani P, Limousin P, Damier P, Arnulf I, Benabid AL, Agid Y, Pollak P (1999) Bilateral subthalamic or pallidal stimulation for Parkinson’s disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 46(2):217–223

    Article  PubMed  CAS  Google Scholar 

  4. Bejjani BP, Dormont D, Pidoux B, Yelnik J, Damier P, Arnulf I, Bonnet AM, Marsault C, Agid Y, Philippon J, Cornu P (2000) Bilateral subthalamic stimulation for Parkinson’s disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg 92(4):615–625

    PubMed  CAS  Google Scholar 

  5. Capecci M, Ricciuti RA, Burini D, Bombace VG, Provinciali L, Iacoangeli M, Scerrati M, Ceravolo MG (2005) Functional improvement after subthalamic stimulation in Parkinson’s disease: a non-equivalent controlled study with 12–24 month follow up. J Neurol Neurosurg Psychiatry 76:769–774

    Article  PubMed  CAS  Google Scholar 

  6. Capus L, Melatini A, Zorzon M, Torre P, Carraro N, Moretti D, Gioulis M, Moretti R, Sarra MV, Marsala SZ (2001) Chronic bilateral electrical stimulation of the subthalamic nucleus for the treatment of advanced Parkinson’s disease. Neurol Sci 22(1):57–58

    Article  PubMed  CAS  Google Scholar 

  7. Contarino MF, Daniele A, Sibilia AH, Romito LM, Bentivoglio AR, Gainotti G, Albanese A (2007) Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 78(3):248–252

    Article  PubMed  CAS  Google Scholar 

  8. Czernecki V, Pillon B, Houeto JL, Welter ML, Mesnage V, Agid Y, Dubois B (2005) Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson’s disease? J Neurol Neurosurg Psychiatry 76:775–779

    Article  PubMed  CAS  Google Scholar 

  9. Deep brain stimulation study group (2001) Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med 345(13):956–963

    Google Scholar 

  10. Derost PP, Ouchchane L, Morand D, Ulla M, Llorca PM, Barget M, Debilly B, Lemaire JJ, Durif F (2007) Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? Neurology 68(17):1345–1355

    Article  PubMed  Google Scholar 

  11. Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schafer H, Botzel K, Daniels C, Deutschlander A, Dillmann U, Eisner W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, Kloss M, Koy J, Krause M, Kupsch A, Lorenz D, Lorenzl S, Mehdorn HM, Moringlane JR, Oertel W, Pinsker MO, Reichmann H, Reuss A, Schneider GH, Schnitzler A, Steude U, Sturm V, Timmermann L, Tronnier V, Trottenberg T, Wojtecki L, Wolf E, Poewe W, Voges J; German Parkinson Study Group (2006) Neurostimulation Section. A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 355(9):896–908

    Article  PubMed  CAS  Google Scholar 

  12. Esselink RA, de Bie RM, de Haan RJ, Lenders MW, Nijssen PC, Staal MJ, Smeding HM, Schuurman PR, Bosch DA, Speelman JD (2004) Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomised trial. Neurology 62(2):201–207

    PubMed  CAS  Google Scholar 

  13. Fahn S, Elton RL for the UPDRS Development Commitee (1987) Unified Parkinson’s disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M (eds) Recent development in Parkinson’s disease. Vol 2. Florham Park, NJ: Mac Millan Healthcare Information, pp 153–163

  14. Faist M, Xie J, Kurz D, Berger W, Maurer C, Pollak P, Lucking CH (2001) Effect of bilateral subthalamic nucleus stimulation on gait in Parkinson’s disease. Brain 124:1590–1600

    Article  PubMed  CAS  Google Scholar 

  15. Ford B, Winfield L, Pullman SL, Frucht SJ, Du Y, Greene P, Cheringal JH, Yu Q, Cote LJ, Fahn S, McKhann II GM, Goodman RR (2004) Subthalamic nucleus stimulation in advanced Parkinson’s disease: blinded assessments at one year follow up. J Neurol Neurosurg Psychiatry 75:1255–1259

    Article  PubMed  CAS  Google Scholar 

  16. Fraix V, Pollak P, Van Blercom N, Xie J, Krack P, Koudsie A, Benabid AL (2000) Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson’s disease. Neurology 55(12):1921–1923

    PubMed  CAS  Google Scholar 

  17. Funkiewiez A, Ardouin C, Caputo E, Krack P, Fraix V, Klinger H, Chabardes S, Foote K, Benabid AL, Pollak P (2004) Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson’s disease. J Neurol Neurosurg Psychiatry 75(6):834–839

    Article  PubMed  CAS  Google Scholar 

  18. Gan J, Xie-Brustolin J, Mertens P, Polo G, Klinger H, Mollion H, Benatru I, Henry E, Broussolle E, Thobois S (2007) Bilateral subthalamic nucleus stimulation in advanced Parkinson’s disease: three years follow-up. J Neurol 254(1):99–106

    Article  PubMed  Google Scholar 

  19. Hilker R, Portman AT, Voges J, Staal MJ, Burghaus L, van Laar T, Koulousakis A, Maguire RP, Pruim J, de Jong BM, Herholz K, Sturm V, Heiss WD, Leenders KL (2005) Disease progression continues in patients with advanced Parkinson’s disease and effective subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry 76:1217–1221

    Article  PubMed  CAS  Google Scholar 

  20. Herzog J, Volkmann J, Krack P, Kopper F, Potter M, Lorenz D, Steinbach M, Klebe S, Hamel W, Schrader B, Weinert D, Muller D, Mehdorn HM, Deuschl G (2003) Two-year follow-up of subthalamic deep brain stimulation in Parkinson’s disease. Mov Disord 18(11):1332–1337

    Article  PubMed  Google Scholar 

  21. Houeto JL, Damier P, Bejjani PB, Staedler C, Bonnet AM, Arnulf I, Pidoux B, Dormont D, Cornu P, Agid Y (2000) Subthalamic stimulation in Parkinson disease: a multidisciplinary approach. Arch Neurol 57(4):461–465

    Article  PubMed  CAS  Google Scholar 

  22. Houeto JL, Mesnage V, Mallet L, Pillon B, Gargiulo M, du Moncel ST, Bonnet AM, Pidoux B, Dormont D, Cornu P, Agid Y (2002) Behavioural disorders, Parkinson’s disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry 72(6):701–707

    Article  PubMed  CAS  Google Scholar 

  23. Kleiner-Fisman G, Fisman DN, Sime E, Saint-Cyr JA, Lozano AM, Lang AE (2003) Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J Neurosurg 99:489–495

    PubMed  Google Scholar 

  24. Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, Lang AE, Deuschl G (2006) Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 21(Suppl 14):S290–S304

    Article  PubMed  Google Scholar 

  25. Krack P, Pollak P, Limousin P, Hoffmann D, Xie J, Benazzouz A, Benabid AL (1998) Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson’s disease. Brain 121:451–457

    Article  PubMed  Google Scholar 

  26. Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF, Benabid AL, Pollak P (2003) Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 349:1925–1934

    Article  PubMed  CAS  Google Scholar 

  27. Kumar R, Lozano AM, Kim YJ, Hutchison WD, Sime E, Halket E, Lang AE (1998) Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson’s disease. Neurology 51(3):850–855

    PubMed  CAS  Google Scholar 

  28. Liang GS, Chou KL, Baltuch GH, Jaggi JL, Loveland-Jones C, Leng L, Maccarone H, Hurtig HI, Colcher A, Stern MB, Kleiner-Fisman G, Simuni T, Siderowf AD (2006). Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson’s disease. Stereotact Funct Neurosurg 84(5–6):221–227

    Article  PubMed  Google Scholar 

  29. Limousin P, Krack P, Pollack P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL (1998) Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 339(16):1105–1111

    Article  PubMed  CAS  Google Scholar 

  30. Limousin P, Pollack P, Benazzouz A, Hoffmann D, Le Bas JF, Broussolle E, Perret JE, Benabid AL (1995) Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345(8942):91–95

    Article  PubMed  CAS  Google Scholar 

  31. Lopiano L, Rizzone M, Bergamasco B, Tavella A, Torre E, Perozzo P, Valentini MC, Lanotte M (2001) Deep brain stimulation of the subthalamic nucleus: clinical effectiveness and safety. Neurology 56:552–554

    PubMed  CAS  Google Scholar 

  32. Molinuevo JL, Valldeoriola F, Tolosa E, Rumia J, Valls-Sole J, Roldan H, Ferrer E (2000) Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. Arch Neurol 57(7):983–988

    Article  PubMed  CAS  Google Scholar 

  33. Moro E, Scerrati M, Romito LM, Roselli R, Tonali P, Albanese A (1999) Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson’s disease. Neurology 53(1):85–90

    PubMed  CAS  Google Scholar 

  34. Ostergaard K, Sunde N, Dupont E (2002) Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson’s disease and motor fluctuations. Mov Disord 17(4):693–700

    Article  PubMed  Google Scholar 

  35. Ostergaard K, Sunde N (2006) Evolution of Parkinson’s disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus. Mov Disord 21(5):624–631

    Article  PubMed  Google Scholar 

  36. Pahwa R, Wilkinson SB, Overman J, Lyons KE (2003) Bilateral subthalamic stimulation in patients with Parkinson disease: long-term follow-up. J Neurosurg 99(1):71–77

    PubMed  Google Scholar 

  37. Pinter MM, Alesch F, Murg M,Seiwald M, Helscher RJ, Binder H (1999) Deep brain stimulation of the subthalamic nucleus for control of extrapyramidal features in advanced idiopathic Parkinson’s disease: one year follow-up. J Neural Transm 106:693–709

    Article  PubMed  CAS  Google Scholar 

  38. Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto J-L, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Volkmann J, Hariz MI, Quinn NP, Speelman JD, Guridi J, Zamarbide I, Gironell A, Molet J, Pascual-Sedano B, Pidoux B, Bonnet AM, Agid Y, Xie J, Benabid A-L, Lozano AM, Saint Cyr J, Romito L, Contarino F, Scerrati M, Fraix V, Van Blercom N (2005) Bilateral deep brain stimulation in Parkinson’s disease: a multicentre study with 4 years followup. Brain 128:2240–2249

    Article  PubMed  CAS  Google Scholar 

  39. Romito LM, Scerrati M, Contarino MF, Bentivoglio AR, Tonali P, Albanese A (2002) Long-term follow up of subthalamic nucleus stimulation in Parkinson’s disease. Neurology 58(10):1546–1550

    PubMed  CAS  Google Scholar 

  40. Russmann H, Ghika J, Villemure JG, Robert B, Bogousslavsky J, Burkhard PR, Vingerhoets FJ (2004) Subthalamic nucleus deep brain stimulation in P arkinson disease patients over age 70 years old. Neurology 65:179–180

    Google Scholar 

  41. Schupbach WM, Chastan N, Welter ML, Houeto JL, Mesnage V, Bonnet AM, Czernecki V, Maltete D, Hartmann A, Mallet L, Pidoux B, Dormont D, Navarro S, Cornu P, Mallet A, Agid Y (2005). Stimulation of the subthalamic nucleus in Parkinson’s disease: a 5 year follow-up. J Neurol Neurosurg Psychiatry 76:1640–1644

    Article  PubMed  CAS  Google Scholar 

  42. Schupbach WM, Maltete D, Houeto JL, du Montcel ST, Mallet L, Welter ML, Gargiulo M, Behar C, Bonnet AM, Czernecki V, Pidoux B, Navarro S, Dormont D, Cornu P, Agid Y (2007) Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology 23; 68(4):267–271

    Article  PubMed  CAS  Google Scholar 

  43. Scotto di Luzio AE, Ammannati F, Marini P, Sorbi S, Mennonna P (2001) Which target for DBS in Parkinson’s disease? Subthalamic nucleus versus globus pallidus internus. Neurol Sci 22(1):87–88

    Article  Google Scholar 

  44. Simuni T, Jaggi JL, Mulholland H, Hurtig H, Colcher A, Siderowf AD, Ravina B, Skolnick BE, Goldstein R, Stern MB, Baltuch GH (2002) Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safety. J Neurosurg 96:666–672

    Article  PubMed  Google Scholar 

  45. Thobois S, Mertens P, Guenot M, Hermier M, Mollion H, Bouvard M, Chazot G, Broussolle E, Sindou M (2002) Subthalamic nucleus stimulation in Parkinson’s disease: clinical evaluation of 18 patients. J Neurol 249:529–534

    Article  PubMed  CAS  Google Scholar 

  46. Thobois S, Corvaisier S, Mertens P, Di Guardo C, Mollion H, Guenot M, Rochefort F, Chazot G, Sindou M, Broussolle E (2003) The timing of antiparkinsonian treatment reduction after subthalamic nucleus stimulation. Eur Neurol 49(1):59–63

    Article  PubMed  CAS  Google Scholar 

  47. Thobois S (2006). Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson’s disease: A review of the literature. Clinical Therapeutics 28:1–12

    Article  PubMed  CAS  Google Scholar 

  48. Tir M, Devos D, Blond S, Touzet G, Reyns N, Duhamel A, Cottencin O, Dujardin K, Cassim F, Destee A, Defebvre L, Krystkowiak P (2007) Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients. Neurosurgery 61(2):297–304

    Article  PubMed  Google Scholar 

  49. Visser-Vandewalle V, van der Linden C, Temel Y, Celik H, Ackermans L, Spincemaille G, Caemaert J (2005) Long-term effects of bilateral subthalamic nucleus stimulation in advanced Parkinson disease: a four year follow-up. Parkinsonism and Related disease 11:157–165

    Article  Google Scholar 

  50. Vingerhoets FJ, Villemure JG, Temperli P, Pollo C, Pralong E, Ghika J (2002) Subthalamic DBS replaces levodopa in Parkinson’s disease: two-year followup Neurology 58(3):396–401

    PubMed  Google Scholar 

  51. Volkmann J, Allert N, Voges J, Weiss PH, Freund HJ, Sturm V (2001) Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology 56:548–551

    PubMed  CAS  Google Scholar 

  52. Wider C, Pollo C, Bloch J, Burkhard PR, Vingerhoets FJ (2008) Long-term outcome of 50 consecutive Parkinson’s disease patients treated with subthalamic deep brain stimulation. Parkinsonism Relat Disord 14(2):114–119

    Article  PubMed  CAS  Google Scholar 

  53. Terao T, Takahashi H, Yokochi F, Taniguchi M, Okiyama R, Hamada I (2003). Hemorrhagic complication of stereotactic surgery in patients with movement disorders. J Neurosurg 98(6):1241–1246

    PubMed  Google Scholar 

  54. Czernecki V, Schupbach M, Yaici S, Levy R, Bardinet E, Yelnik J, Dubois B, Agid Y (2008) Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom. Mov Disord 23(7):964–969

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Thobois MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gervais-Bernard, H., Xie-Brustolin, J., Mertens, P. et al. Bilateral subthalamic nucleus stimulation in advanced Parkinson’s disease: Five year follow-up. J Neurol 256, 225–233 (2009). https://doi.org/10.1007/s00415-009-0076-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-009-0076-2

Key words

Navigation